Table 3 The effect of clustering of metabolic syndrome components on the risk of IGT, determined by logistic regression
| Â | Number of clustering | Prevalence n (%) | Number of IGT (%) | OR (95% CI) | The combination of metabolic components in the cluster with the most prevalent rate of IGT |
|---|---|---|---|---|---|
Including hyperglycemia | 0 | 189 (20.4) | 13 (6.9) | Ref | Â |
| Â | 1 | 200 (21.6) | 29 (14.5) | 1.71 (0.85-3.46) | hyperglycemia |
|  | 2 | 230 (24.8) | 51 (22.2) | 2.38 (1.22-4.67) | hyperglycemia + high BP |
|  | ≥3 | 309 (33.2) | 129 (41.7) | 5.92 (3.12-11.21) | hyperglycemia + high BP + central obesity |
Without hyperglycemia | Â | Â | Â | Â | Â |
| Â | 1 | 178 (27.1) | 24 (13.4) | 1.53 (0.74-3.19) | Central obesity |
|  | 2 | 169 (25.8) | 35 (20.6) | 2.21 (1.08-4.53) | Central obesity + high BP |
|  | ≥3 | 120 (18.3) | 38 (31.7) | 4.44 (2.14-9.20) | Central obesity + high BP + high TG |